<i>N</i> -alkyl and <i>N</i> -benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors

COVID-19 pandemic stimulated tremendous efforts to develop therapeutic strategies targeting SARS-CoV-2, leading to the evaluation of a wide range of potential treatments in clinical trials. However, effective therapeutics remain elusive when the development of new variants and the limits of antiviral drugs is considered. Therefore, the development of antiviral drugs against SARS-CoV-2 is of paramount importance. Among potential drug targets, the SARS-CoV-2 nsp13 is highly attractive thanks to its pivotal role in viral replication. Pursuing our studies on the development of nsp13 inhibitors, in this work we describe the design, synthesis, and biological evaluation of novel inhibitors targeting SARS-CoV-2 nsp13. The newly designed <i>N</i>-benzyl indole derivatives were active against both enzymatic activities showing measurable IC<sub>50</sub> under 30 μM concentration, while <i>N</i>-alkyl derivatives showed less promising results. Interestingly, the tested compounds blocked viral replication with no cytotoxicity. Docking studies predicted their binding into an allosteric conserved site located in the RecA2 domain.

Authors

Institutions

Publication Details

Journal
Journal of Enzyme Inhibition and Medicinal Chemistry
Published
2025-08-12
DOI
https://doi.org/10.1080/14756366.2025.2539445
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

N -alkyl and N -benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors

Giuseppe Ruggieri, Davide Ialongo, Luigi Scipione, Enzo Tramontano et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
Computational Drug Discovery Methods
article

N -alkyl and N -benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors

Giuseppe Ruggieri, Davide Ialongo, Luigi Scipione, Enzo Tramontano, Valentina Noemi Madia, Roberta Costi, Roberto Di Santo, Elisa Patacchini, Angela Corona, Francesco Saccoliti, Florigio Lista, Merve Arpacioglu, Stefania Maloccu, Roberta Emmolo, Francesca Esposito, Giorgia Grilli, Riccardo De Santis, Aurora Albano, Donatella Amatore
article en

Abstract

COVID-19 pandemic stimulated tremendous efforts to develop therapeutic strategies targeting SARS-CoV-2, leading to the evaluation of a wide range of potential treatments in clinical trials. However, effective therapeutics remain elusive when the development of new variants and the limits of antiviral drugs is considered. Therefore, the development of antiviral drugs against SARS-CoV-2 is of paramount importance. Among potential drug targets, the SARS-CoV-2 nsp13 is highly attractive thanks to its pivotal role in viral replication. Pursuing our studies on the development of nsp13 inhibitors, in this work we describe the design, synthesis, and biological evaluation of novel inhibitors targeting SARS-CoV-2 nsp13. The newly designed <i>N</i>-benzyl indole derivatives were active against both enzymatic activities showing measurable IC<sub>50</sub> under 30 μM concentration, while <i>N</i>-alkyl derivatives showed less promising results. Interestingly, the tested compounds blocked viral replication with no cytotoxicity. Docking studies predicted their binding into an allosteric conserved site located in the RecA2 domain.

Journal of Enzyme Inhibition and Medicinal ChemistryVol. 40(1)
University of Pavia (IT), Istituto di Scienze Marine del Consiglio Nazionale delle Ricerche (IT), Istituto Nazionale di Fisica Nucleare, Sezione di Cagliari (IT), Istituto Pasteur (IT), Institute of Cognitive Sciences and Technologies (IT), Link Campus University (IT), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 78%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.